Literature DB >> 8677398

Multi-state models and diabetic retinopathy.

G Marshall1, R H Jones.   

Abstract

This paper discusses the application of a multi-state model to diabetic retinopathy under the assumption that a continuous time Markov process determines the transition times between disease stages. The multi-state model consists of three transient states that represent the early stages of retinopathy, and one final absorbing state that represent the irreversible stage of retinopathy. By using a model with covariables, we explore the effects of factors that influence the onset, progression, and regression of diabetic retinopathy among subjects with insulin-dependent diabetes mellitus. We can also introduce time-dependent covariables in the model by assuming that the covariables remain constant between two observations. We can also obtain survival-type curves from each stage of the disease and for any combination of patient risk factors.

Entities:  

Mesh:

Year:  1995        PMID: 8677398     DOI: 10.1002/sim.4780141804

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  29 in total

1.  Multi-state models in epidemiology.

Authors:  D Commenges
Journal:  Lifetime Data Anal       Date:  1999-12       Impact factor: 1.588

2.  Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.

Authors:  David M Nathan; Ionut Bebu; Dean Hainsworth; Ronald Klein; William Tamborlane; Gayle Lorenzi; Rose Gubitosi-Klug; John M Lachin
Journal:  N Engl J Med       Date:  2017-04-20       Impact factor: 91.245

3.  A model-informed rank test for right-censored data with intermediate states.

Authors:  Ritesh Ramchandani; Dianne M Finkelstein; David A Schoenfeld
Journal:  Stat Med       Date:  2015-01-13       Impact factor: 2.373

4.  Optimal screening schedules for disease progression with application to diabetic retinopathy.

Authors:  Ionut Bebu; John M Lachin
Journal:  Biostatistics       Date:  2018-01-01       Impact factor: 5.899

5.  Misclassification can explain most apparent regression of age-related macular degeneration: results from multistate models with misclassification.

Authors:  Ronald E Gangnon; Kristine E Lee; Barbara E K Klein; Sudha K Iyengar; Theru A Sivakumaran; Ronald Klein
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

6.  Betting on change: modeling transitional probabilities to guide therapy development for opioid dependence.

Authors:  Kenneth M Carpenter; Huiping Jiang; Maria A Sullivan; Adam Bisaga; Sandra D Comer; Wilfrid Noel Raby; Adam C Brooks; Edward V Nunes
Journal:  Psychol Addict Behav       Date:  2009-03

7.  Factors that influence entry into stages of the menopausal transition.

Authors:  Mary D Sammel; Ellen W Freeman; Ziyue Liu; Hui Lin; Wensheng Guo
Journal:  Menopause       Date:  2009 Nov-Dec       Impact factor: 2.953

8.  The natural history of trachoma infection and disease in a Gambian cohort with frequent follow-up.

Authors:  Nicholas C Grassly; Michael E Ward; Shirley Ferris; David C Mabey; Robin L Bailey
Journal:  PLoS Negl Trop Dis       Date:  2008-12-02

9.  Effect of the Y402H variant in the complement factor H gene on the incidence and progression of age-related macular degeneration: results from multistate models applied to the Beaver Dam Eye Study.

Authors:  Ronald E Gangnon; Kristine E Lee; Barbara E K Klein; Sudha K Iyengar; Theru A Sivakumaran; Ronald Klein
Journal:  Arch Ophthalmol       Date:  2012-09

10.  Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C.

Authors:  Norah A Terrault; Kelly Im; Ross Boylan; Peter Bacchetti; David E Kleiner; Robert J Fontana; Jay H Hoofnagle; Steven H Belle
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08-19       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.